NLRP3 and steatosis: We also provided an alternative mechanism by which ATL I binds with SIRT6 to activate PPARα and its target genes and suppresses inflammatory factor release by attenuating NFκB-mediated NLRP3 inflammasome formation, which, together, attenuate hepatic inflammation and steatosis.